(2026). Engineered immune cells and extracellular vesicles target tumour microenvironment barriers in solid tumour immunotherapy. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Engineered Immune Cells and Extracellular Vesicles Target Tumour Microenvironment Barriers in Solid Tumour Immunotherapy."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Engineered Immune Cells and Extracellular Vesicles Target Tumour Microenvironment Barriers in Solid Tumour Immunotherapy."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.